Shinto Organics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 07-07-2024
- Paid Up Capital ₹ 2.50 M
as on 07-07-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.75 Cr
as on 07-07-2024
- Revenue -41.72%
(FY 2022)
- Profit -50.66%
(FY 2022)
- Ebitda -72.84%
(FY 2022)
- Net Worth 3.79%
(FY 2022)
- Total Assets -1.85%
(FY 2022)
About Shinto Organics
The Corporate was formerly known as Shinto Biotec Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹2.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Harsh Gulati and Usha Gulati serve as directors at the Company.
- CIN/LLPIN
U24231CH1994PTC015041
- Company No.
015041
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 1994
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationU T, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shinto Organics?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harsh Gulati | Managing Director | 15-Mar-1997 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Usha Gulati | Whole-Time Director | 30-Sep-2002 | Current |
Financial Performance and Corporate Structure Insights of Shinto Organics.
Shinto Organics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.72% decrease. The company also saw a substantial fall in profitability, with a 50.66% decrease in profit. The company's net worth moved up by a moderate rise of 3.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shinto Organics?
In 2020, Shinto Organics had a promoter holding of 49.83% and a public holding of 50.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Union Bank Of India Creation Date: 10 Oct 2013 | ₹2.50 M | Satisfied |
Union Bank Of India Creation Date: 02 Jun 2011 | ₹2.25 Cr | Satisfied |
Punjab National Bank Creation Date: 02 Sep 2002 | ₹2.45 M | Satisfied |
How Many Employees Work at Shinto Organics?
Unlock and access historical data on people associated with Shinto Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shinto Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shinto Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.